Literature DB >> 1901079

Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.

M A Alexander1, C A Damico, K M Wieties, T H Hansen, J M Connolly.   

Abstract

We have taken advantage of some unique properties of H-2Ld to investigate the determinant density requirements for cytotoxic T lymphocyte (CTL) priming versus effector function and to correlate the determinant density requirements with CD8 dependency. In a previous study (Lie, W.-R., N. B. Myers, J. Gorka, R. J. Rubocki, J. M. Connolly, and T. H. Hansen. 1990. Nature [Lond.]. 344:439), we demonstrated that culturing normal cells with peptides known to be restricted by H-2Ld led to a two- to fourfold increase in surface Ld expression. In the present study, we demonstrate the generation of Ld-restricted, peptide-specific in vitro primary CTL by culturing spleen cells with murine cytomegalovirus or tum- peptide at concentrations previously shown to result in maximum induction of Ld expression. Target cells can be sensitized for recognition by these CTL with lower dose of peptide than are required for the primary sensitization. This demonstrates differences in the determinant density requirements for priming versus effector function. The in vitro primary CTL generated with peptide can weakly lyse target cells that express the determinant endogenously, and CTL lines and clones capable of strong lysis of endogenous expressors are easily obtained. In both cases, target cells treated with exogenous peptide are lysed better than target cells expressing antigen endogenously. This suggested that there are differences in the determinant density of peptide-fed versus endogenous targets. This interpretation was substantiated when it was observed that the level of lysis of target cells expressing endogenous determinants correlated inversely with the amount of peptide required to sensitize targets for recognition by various tum- -specific CTL clones. Furthermore, simultaneous titration of both the peptide used to treat target cells and the antibody to CD8 revealed that the various CTL clones analyzed displayed widely disparate CD8 dependencies. In each case, the CD8 dependency correlated inversely with the determinant density requirement. Therefore, CD8 dependency of CTL is relative, but shows an absolute and quantitative correlation with their dependency on determinant density. These findings suggest that under physiologic conditions, where only low determinant densities are likely to be encountered, all CTL clones will show at least partial CD8 dependency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901079      PMCID: PMC2190800          DOI: 10.1084/jem.173.4.849

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule.

Authors:  J M Connolly; T H Hansen; A L Ingold; T A Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules.

Authors:  S C Johnston; M L Dustin; M L Hibbs; T A Springer
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

3.  Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens.

Authors:  G A Evans; D H Margulies; B Shykind; J G Seidman; K Ozato
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

4.  Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells.

Authors:  S H Gromkowski; W Heagy; F Sanchez-Madrid; T A Springer; E Martz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

5.  Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity.

Authors:  R Bernards; P I Schrier; A Houweling; J L Bos; A J van der Eb; M Zijlstra; C J Melief
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

6.  Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk.

Authors:  L R Gooding
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  Aggressiveness of SJL/J lymphomas correlates with absence of H-2Ds antigens.

Authors:  E F Rosloniec; M H Kuhn; C A Genyea; A H Reed; J J Jennings; A A Giraldo; K W Beisel; S P Lerman
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells.

Authors:  P I Schrier; R Bernards; R T Vaessen; A Houweling; A J van der Eb
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

9.  Automated synthesis of a C-terminal photoprobe using combined Fmoc and t-Boc synthesis strategies on a single automated peptide synthesizer.

Authors:  J Gorka; D W McCourt; B D Schwartz
Journal:  Pept Res       Date:  1989 Nov-Dec

10.  T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.

Authors:  J A Ledbetter; R V Rouse; H S Micklem; L A Herzenberg
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  36 in total

1.  Extensive peptide ligand exchange by surface class I major histocompatibility complex molecules independent of exogenous beta 2-microglobulin.

Authors:  J D Smith; W R Lie; J Gorka; N B Myers; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.

Authors:  T J Goletz; K R Klimpel; N Arora; S H Leppla; J M Keith; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract.

Authors:  Peter M Gray; Subhashini Arimilli; Ellen M Palmer; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Authors:  M A Alexander-Miller; G R Leggatt; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

5.  Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

Authors:  M A Alexander-Miller; G R Leggatt; A Sarin; J A Berzofsky
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

6.  HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.

Authors:  A Bertoletti; C Ferrari; F Fiaccadori; A Penna; R Margolskee; H J Schlicht; P Fowler; S Guilhot; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 7.  Applications of major histocompatibility complex class I molecules expressed as single chains.

Authors:  Tina Primeau; Nancy B Myers; Y Y Lawrence Yu; Lonnie Lybarger; Xiaoli Wang; Steven M Truscott; Ted H Hansen; Janet M Connolly
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

Authors:  Katayoun Rezvani; Agnes S M Yong; Abdul Tawab; Behnam Jafarpour; Rhoda Eniafe; Stephan Mielke; Bipin N Savani; Keyvan Keyvanfar; Yixin Li; Roger Kurlander; A John Barrett
Journal:  Blood       Date:  2008-11-06       Impact factor: 22.113

9.  Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter.

Authors:  Charles J Kroger; Martha A Alexander-Miller
Journal:  Immunology       Date:  2007-05-02       Impact factor: 7.397

10.  The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.

Authors:  J M Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.